[144] Cencora, Inc. SEC Filing
Rhea-AI Filing Summary
Elizabeth Campbell filed a Rule 144 notice to sell 3,351 shares of common stock through Fidelity Brokerage Services LLC, with an aggregate market value of 1146377.10, on or about 12/19/2025 on the NYSE. The issuer had 193993444 shares of this class outstanding.
The shares to be sold were acquired from the issuer as compensation via restricted stock vesting on three dates in November 2024: 1,257 shares on 11/08/2024, 1,391 shares on 11/09/2024, and 703 shares on 11/10/2024. Over the past three months, Campbell previously sold 1,886 common shares on 10/01/2025 for gross proceeds of 590846.08.
Positive
- None.
Negative
- None.
FAQ
What does the Form 144 filing for COR disclose?
The filing discloses that Elizabeth Campbell intends to sell 3,351 shares of common stock under Rule 144, with an aggregate market value of 1146377.10, through Fidelity Brokerage Services LLC on or about 12/19/2025 on the NYSE.
How many COR shares has the insider recently sold or plans to sell?
The notice covers a planned sale of 3,351 common shares. It also reports that the same person sold 1,886 common shares on 10/01/2025 for gross proceeds of 590846.08 during the past three months.
How and when were the COR shares in this Form 144 acquired?
The shares were acquired from the issuer as restricted stock vesting used as compensation: 1,257 shares on 11/08/2024, 1,391 shares on 11/09/2024, and 703 shares on 11/10/2024, with payment described as compensation on each date.
What is the size of the planned COR share sale relative to shares outstanding?
The planned sale involves 3,351 common shares, while the filing reports that 193993444 common shares of the issuer were outstanding for this class.
Which broker and exchange are involved in the COR Form 144 sale?
The shares are to be sold through Fidelity Brokerage Services LLC, and the filing lists the NYSE as the securities exchange for the sale.
What representation does the insider make in this Form 144 for COR?
By signing the notice, the person for whose account the securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.